The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients

The records of patients who were diagnosed with ARN between April 2010 and February 2017 were analyzed.A retrospective review of the treatment options and outcomes of the these patients was performed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Retinal Necrosis Eye Diseases Retinal Diseases Retinal Necrosis Syndrome, Acute Retinitis

Age range

18 year and older

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

ARN was diagnosed according to the American Uveitis Society Diagnostic Criteria (1994)

Exclusion criteria

Treatment and study plan

pars plana vitrectomy

Procedure

pars plana vitrectomy

Other names: systemic antiviral medications

Primary outcomes

visual acuity

Time frame: 1 year

Secondary outcomes

retinal detachement

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Chongqing Medical University

Other

Registry information

Important dates

Study start: 2012
Primary completion: 2017
Study completion: 2017
First posted: Aug 24, 2017
Registry last updated: Aug 24, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed